This inventor holds 3 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 2002-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2008
Title: Kenneth G Mandel: Innovator in Pharmaceutical Composition
Introduction
Kenneth G Mandel is a notable inventor based in Parsippany, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compositions that enhance the efficacy of medications. With a total of 3 patents to his name, Mandel's work has had a meaningful impact on the industry.
Latest Patents
Mandel's latest patents include innovative formulations of lipstatin derivatives. One of his key inventions is the "Lipstatin derivative—soluble fiber tablets," which relates to a novel pharmaceutical composition and process for preparing swallowable rapidly disintegrating methylcellulose and lipstatin derivatives together in combination with suitable diluents and excipients. This invention aims to improve the delivery and effectiveness of the medication.
Career Highlights
Kenneth G Mandel has been associated with SmithKline Beecham Corporation, where he has contributed to various research and development projects. His expertise in pharmaceutical formulations has positioned him as a valuable asset to the company.
Collaborations
Mandel has worked alongside his coworker, Bruce P Daggy, to advance their research initiatives. Their collaboration has focused on enhancing the effectiveness of pharmaceutical compositions.
Conclusion
Kenneth G Mandel's innovative work in pharmaceutical compositions demonstrates his commitment to improving medication delivery systems. His contributions continue to influence the field and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile